EDTXF
Price
$1.05
Change
-$0.04 (-3.67%)
Updated
Sep 24 closing price
Capitalization
305.63M
42 days until earnings call
TDSGF
Price
$0.05
Change
-$0.01 (-16.67%)
Updated
Sep 25 closing price
Capitalization
5.44M
Interact to see
Advertisement

EDTXF vs TDSGF

Header iconEDTXF vs TDSGF Comparison
Open Charts EDTXF vs TDSGFBanner chart's image
Spectral Medical
Price$1.05
Change-$0.04 (-3.67%)
Volume$4K
Capitalization305.63M
Telo Genomics
Price$0.05
Change-$0.01 (-16.67%)
Volume$1.2K
Capitalization5.44M
EDTXF vs TDSGF Comparison Chart in %
Loading...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDTXF vs. TDSGF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDTXF is a Hold and TDSGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (EDTXF: $1.05 vs. TDSGF: $0.05)
Brand notoriety: EDTXF and TDSGF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDTXF: 16% vs. TDSGF: 5%
Market capitalization -- EDTXF: $305.63M vs. TDSGF: $5.44M
EDTXF [@Medical Specialties] is valued at $305.63M. TDSGF’s [@Medical Specialties] market capitalization is $5.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDTXF’s FA Score shows that 1 FA rating(s) are green whileTDSGF’s FA Score has 0 green FA rating(s).

  • EDTXF’s FA Score: 1 green, 4 red.
  • TDSGF’s FA Score: 0 green, 5 red.
According to our system of comparison, EDTXF is a better buy in the long-term than TDSGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDTXF’s TA Score shows that 3 TA indicator(s) are bullish while TDSGF’s TA Score has 4 bullish TA indicator(s).

  • EDTXF’s TA Score: 3 bullish, 5 bearish.
  • TDSGF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TDSGF is a better buy in the short-term than EDTXF.

Price Growth

EDTXF (@Medical Specialties) experienced а -3.23% price change this week, while TDSGF (@Medical Specialties) price change was +7.65% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.65%. For the same industry, the average monthly price growth was +2.63%, and the average quarterly price growth was +23.73%.

Reported Earning Dates

EDTXF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Medical Specialties (-2.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDTXF($306M) has a higher market cap than TDSGF($5.44M). EDTXF YTD gains are higher at: 202.245 vs. TDSGF (-37.293). TDSGF has higher annual earnings (EBITDA): -2.59M vs. EDTXF (-16.9M). EDTXF has more cash in the bank: 3.1M vs. TDSGF (1.25M). EDTXF has higher revenues than TDSGF: EDTXF (2.53M) vs TDSGF (0).
EDTXFTDSGFEDTXF / TDSGF
Capitalization306M5.44M5,623%
EBITDA-16.9M-2.59M652%
Gain YTD202.245-37.293-542%
P/E RatioN/AN/A-
Revenue2.53M0-
Total Cash3.1M1.25M248%
Total Debt17.6MN/A-
FUNDAMENTALS RATINGS
EDTXF vs TDSGF: Fundamental Ratings
EDTXF
TDSGF
OUTLOOK RATING
1..100
8290
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3785
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TDSGF's Valuation (42) in the null industry is somewhat better than the same rating for EDTXF (87). This means that TDSGF’s stock grew somewhat faster than EDTXF’s over the last 12 months.

EDTXF's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for TDSGF (100). This means that EDTXF’s stock grew significantly faster than TDSGF’s over the last 12 months.

EDTXF's SMR Rating (100) in the null industry is in the same range as TDSGF (100). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

EDTXF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for TDSGF (85). This means that EDTXF’s stock grew somewhat faster than TDSGF’s over the last 12 months.

EDTXF's P/E Growth Rating (100) in the null industry is in the same range as TDSGF (100). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDTXFTDSGF
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGDVX17.49N/A
N/A
TCW Relative Value Large Cap N
FSAAX17.37N/A
N/A
Fidelity Advisor Asset Manager 60% A
MSAYX24.56N/A
N/A
Morgan Stanley Inst Asia Opp R6
GSCGX36.65N/A
N/A
Goldman Sachs Large Cap Equity A
VSNGX66.98N/A
N/A
JPMorgan Mid Cap Equity I

EDTXF and

Correlation & Price change

A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
N/A
ASAPF - EDTXF
22%
Poorly correlated
-1.88%
KSRBF - EDTXF
21%
Poorly correlated
N/A
TDSGF - EDTXF
20%
Poorly correlated
-4.36%
FSPKF - EDTXF
3%
Poorly correlated
N/A
DSRLF - EDTXF
3%
Poorly correlated
N/A
More

TDSGF and

Correlation & Price change

A.I.dvisor tells us that TDSGF and OPK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDSGF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDSGF
1D Price
Change %
TDSGF100%
-4.36%
OPK - TDSGF
24%
Poorly correlated
-3.38%
PRPO - TDSGF
22%
Poorly correlated
+1.68%
EDTXF - TDSGF
20%
Poorly correlated
N/A
USAQ - TDSGF
10%
Poorly correlated
N/A
UEEC - TDSGF
6%
Poorly correlated
N/A
More